Overview


According to FutureWise analysis the market for surgical stents in 2023 is US$ 10.46 billion, and is expected to reach US$ 22.44 billion by 2031 at a CAGR of 10.00%.

The stent is a tiny tube-like device that is inserted by the physician into a blocked passageway to keep it open. A stent restores the flow of blood or other fluids. A flexible metal or plastic tube is inserted into a vessel or duct to maintain an open passageway. "Stent" refers to a device that is inserted into a structure, often an artery, when a disease such as atherosclerosis narrows it pathologically. In addition to the growth of minimally invasive procedures, advancement in healthcare technology, an increase in unhealthy and hectic lifestyles, an increase in the geriatric population, and an increase in healthcare expenditure are all key factors driving the surgical stents market. As a result of the high cost of these stents as well as the treatment of diseases like chronic diseases and urinary tract infections, strict government regulations regarding approval, and the possibility of errors after surgery and procedure, the surgical procedure is extremely expensive.

The surgical stents industry is working with a sense of urgency and a focus on consumers. Global Surgical Stents market growth is driven by innovation. Since the pandemic, most Surgical Stents companies have been focusing on consumer needs and urgency. In order to market products at competitive prices, efforts are being made to drive costs down across various segments of the value chain. Long-term success will also depend on continued innovation and customer-centric strategies, as well as modernizing and expanding manufacturing. High-quality, critical data and analysis are presented in the report to assist decision-makers in formulating sound business strategies. New traders in the Surgical Stents Market face strong competition from ancient world traders as they attempt to keep up with technological developments, reliability, and the commonplace of product affairs in the market. This Surgical Stents Market report covers general successful parameters, limitations, and additionally provides in-depth illumination of noteworthy data about present and future examples that may impact the market. An in-depth analysis of the current advancements, parameters, and establishments in the Surgical Stents Market has been provided in the comprehensive Surgical Stents Market report.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Surgical Stents Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Surgical Stents Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • B.Braun Melsungen AG
  • Meril Life Sciences Pvt Ltd
  • Boston Scientific Corporation
  • F.Hoffmann-La Roche Ltd
  • ELLA-CS, s.r.o.
  • Abbott
  • Angicocare B.V.
  • Amaranth Medical Pte Ltd

(Note: The list of the major players will be updated with the latest market scenario and trends)
 

By Products

  • Non-vascular Stents
  • Vascular Stents

By Types

  • Cardiac Stents
  • Urinary Stents
  • Biliary Stents
  • Esophageal Stents
  • Prostatic Stents
  • Others

By Application

  • Urinary Tract diseases
  • Cardiac Diseases
  • Others

By End User

  • Hospital
  • Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Surgical Stents Market By Products, By Types, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Surgical Stents Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Surgical Stents Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Surgical Stents Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Surgical Stents Market, By Products Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Non-vascular Stents
        2. Vascular Stents

  • 8.   Surgical Stents Market, By Types Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cardiac Stents
        2. Urinary Stents
        3. Biliary Stents
        4. Esophageal Stents
        5. Prostatic Stents
        6. Others

  • 9.   Surgical Stents Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Urinary Tract diseases
        2. Cardiac Diseases
        3. Others

  • 10.   Surgical Stents Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital
        2. Clinics
        3. Others

  • 11.   North America Surgical Stents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Surgical Stents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Surgical Stents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Surgical Stents Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. B.Braun Melsungen AG
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Meril Life Sciences Pvt Ltd
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Boston Scientific Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. F.Hoffmann-La Roche Ltd
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. ELLA-CS, s.r.o.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Abbott
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Angicocare B.V.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Amaranth Medical Pte Ltd
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients